Pacific Edge shares jump 5 percent on prospect of sales through DHBs

Pacific Edge shares jump 5 percent  on prospect of sales through DHBs
Feb. 10 (BusinessDesk) – Shares of Pacific Edge, which have soared almost 200 percent in the past 12 months, extended their gains after a deal was signed allowing its bladder cancer test to be used District Health Boards. The stock jumped 4.9 cents to $1.72 after the Health Innovation Hub, a government agency set up to allow technology innovations to be commercialised via the nation’s four largest DHBs, signed a commercial agreement for the adoption of Pacific Edge’s Cxbladder test. The four biggest DHBs are Auckland, Waitemata, Counties-Manu...